Acquisition by De La Rosa Abel of 5250 shares of Virios Therapeutics subject to Rule 16b-3
| VIRIDelisted Stock | USD 3.95 0.00 0.00% |
Under 56% of Virios Therapeutics' investor base is looking to short. The analysis of current outlook of investing in Virios Therapeutics Llc suggests that many traders are alarmed regarding Virios Therapeutics' prospects. Virios Therapeutics' investing sentiment shows overall attitude of investors towards Virios Therapeutics Llc.
Virios |
Filed transaction by Virios Therapeutics Llc Director . Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
Virios Therapeutics Fundamental Analysis
We analyze Virios Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Virios Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Virios Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Virios Therapeutics is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Virios Therapeutics Llc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Virios Therapeutics stock to make a market-neutral strategy. Peer analysis of Virios Therapeutics could also be used in its relative valuation, which is a method of valuing Virios Therapeutics by comparing valuation metrics with similar companies.
Peers
Virios Therapeutics Related Equities
| ZURA | Zura Bio | 12.09 | ||||
| ICU | LMF Acquisition | 3.90 | ||||
| CYTO | Altamira Therapeutics | 2.38 | ||||
| PHIO | Phio Pharmaceuticals | 0.81 | ||||
| ZVSA | ZyVersa Therapeutics | 1.77 | ||||
| REVB | Revelation Biosciences | 2.63 | ||||
| IMMX | Immix Biopharma | 3.91 | ||||
| SONN | Sonnet Biotherapeutics | 6.38 | ||||
| CNSP | Cns Pharmaceuticals | 7.69 | ||||
| RNAZ | Transcode Therapeutics | 10.53 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Virios Stock
If you are still planning to invest in Virios Therapeutics Llc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Virios Therapeutics' history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |